Precigen (PGEN) COO receives 44,495 RSUs that vest into shares

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

PRECIGEN, INC. Chief Operating Officer Rutul R. Shah reported equity compensation activity in the form of restricted stock units (RSUs). On March 18, 2026, he received a grant of 44,495 RSUs, each representing one share of common stock, which vested immediately at a price of $0.00 per unit. These RSUs were then exercised and settled into 44,495 shares of Precigen common stock, increasing his direct common stock holdings to 450,454 shares following the transactions.

Insider Trade Summary

44,495 shares exercised/converted

Mixed 3 txns

Insider Shah Rutul R

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	44,495	$0.00	--
Exercise	Restricted Stock Units	44,495	$0.00	--
Exercise	Common Stock	44,495	$0.00	--

Holdings After Transaction: Restricted Stock Units — 44,495 shares (Direct); Common Stock — 450,454 shares (Direct)

Footnotes (1)

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. The RSUs vested immediately upon the grant date.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

03/20/2026 - 07:21 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shah Rutul R

(Last)

(First)

(Middle)

20374 SENECA MEADOWS PARKWAY

(Street)

GERMANTOWN

MARYLAND

20876

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/18/2026		M		44,495	A	⁽¹⁾	450,454	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	03/18/2026		A		44,495		⁽²⁾	⁽²⁾	Common Stock	44,495	$0	44,495	D
Restricted Stock Units	⁽¹⁾	03/18/2026		M			44,495	⁽²⁾	⁽²⁾	Common Stock	44,495	$0	0	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.

2. The RSUs vested immediately upon the grant date.

	/s/ Rutul R. Shah, by Donald P. Lehr, as attorney-in-fact	03/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Precigen (PGEN) report for Rutul R. Shah?

Precigen reported that Chief Operating Officer Rutul R. Shah received a grant of 44,495 restricted stock units that vested immediately. These RSUs were then exercised and converted into 44,495 shares of common stock at no cash cost, increasing his direct share ownership.

How many Precigen (PGEN) restricted stock units were granted to the COO?

The COO was granted 44,495 restricted stock units. Each RSU represents a contingent right to receive one share of Precigen common stock, and in this case all units vested immediately and were settled into 44,495 shares in a non-cash equity compensation transaction.

At what price were Rutul R. Shah’s Precigen (PGEN) RSUs exercised?

The RSUs were exercised at a stated price of $0.00 per unit. This reflects a typical equity award structure where the executive receives shares as compensation rather than buying them in the open market, so no purchase cash outlay is involved for the insider.

How many Precigen (PGEN) common shares does the COO hold after this Form 4?

Following the RSU grant, immediate vesting, and conversion, Rutul R. Shah directly holds 450,454 shares of Precigen common stock. This total reflects the addition of 44,495 newly issued shares from the exercised RSUs to his previously existing direct holdings.

What does it mean that Precigen (PGEN) RSUs vested immediately upon grant?

Immediate vesting means Shah’s right to receive the 44,495 shares became fully earned as of the grant date. Once vested, the RSUs were promptly settled into common stock, turning a contingent right into actual share ownership without a waiting or service period.